Overview

RAAS Inhibitor Drugs in Dialysis Patients

Status:
Unknown status

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

Summary

Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study was undertaken to ascertain whether the upstream of aliskirne, a direct renin inhibitor improves mortality and cardiovascular outcomes in these high-risk population.

Phase:

Phase 4

Details

Lead Sponsor:

Second University of Naples
University of Campania "Luigi Vanvitelli"

Collaborator:

IRCCS San Raffaele